These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
184 related items for PubMed ID: 30183599
1. From VEDOSS to established systemic sclerosis diagnosis according to ACR/EULAR 2013 classification criteria: a French-Italian capillaroscopic survey. Vasile M, Avouac J, Sciarra I, Stefanantoni K, Iannace N, Cravotto E, Valesini G, Allanore Y, Riccieri V. Clin Exp Rheumatol; 2018; 36 Suppl 113(4):82-87. PubMed ID: 30183599 [Abstract] [Full Text] [Related]
4. Progression of patients with Raynaud's phenomenon to systemic sclerosis: a five-year analysis of the European Scleroderma Trial and Research group multicentre, longitudinal registry study for Very Early Diagnosis of Systemic Sclerosis (VEDOSS). Bellando-Randone S, Del Galdo F, Lepri G, Minier T, Huscher D, Furst DE, Allanore Y, Distler O, Czirják L, Bruni C, Guiducci S, Avouac J, Cutolo M, Smith V, Matucci-Cerinic M, Very Early Diagnosis of Systemic Sclerosis collaborators. Lancet Rheumatol; 2021 Dec; 3(12):e834-e843. PubMed ID: 38287630 [Abstract] [Full Text] [Related]
6. More severe nailfold capillaroscopy findings and anti-endothelial cell antibodies. Are they useful tools for prognostic use in systemic sclerosis? Riccieri V, Germano V, Alessandri C, Vasile M, Ceccarelli F, Sciarra I, Di Franco M, Spadaro A, Valesini G. Clin Exp Rheumatol; 2008 Dec; 26(6):992-7. PubMed ID: 19210861 [Abstract] [Full Text] [Related]
7. Does nailfold capillaroscopy help predict future outcomes in systemic sclerosis? A systematic literature review. Paxton D, Pauling JD. Semin Arthritis Rheum; 2018 Dec; 48(3):482-494. PubMed ID: 29602558 [Abstract] [Full Text] [Related]
9. Performance of the new ACR/EULAR classification criteria for systemic sclerosis in clinical practice. Jordan S, Maurer B, Toniolo M, Michel B, Distler O. Rheumatology (Oxford); 2015 Aug; 54(8):1454-8. PubMed ID: 25762528 [Abstract] [Full Text] [Related]
11. Nailfold capillaroscopic changes in patients with idiopathic pulmonary arterial hypertension and systemic sclerosis-related pulmonary arterial hypertension. Corrado A, Correale M, Mansueto N, Monaco I, Carriero A, Mele A, Colia R, Di Biase M, Cantatore FP. Microvasc Res; 2017 Nov; 114():46-51. PubMed ID: 28619664 [Abstract] [Full Text] [Related]
12. Nailfold capillaroscopic parameters and skin telangiectasia patterns in patients with systemic sclerosis. Pizzorni C, Giampetruzzi AR, Mondino C, Facchiano A, Abeni D, Paolino S, Ruaro B, Smith V, Sulli A, Cutolo M. Microvasc Res; 2017 May; 111():20-24. PubMed ID: 27989404 [Abstract] [Full Text] [Related]
13. Early systemic sclerosis: analysis of the disease course in patients with marker autoantibody and/or capillaroscopic positivity. Valentini G, Marcoccia A, Cuomo G, Vettori S, Iudici M, Bondanini F, Santoriello C, Ciani A, Cozzolino D, De Matteis GM, Cappabianca S, Vitelli F, Spanò A. Arthritis Care Res (Hoboken); 2014 Oct; 66(10):1520-7. PubMed ID: 24515450 [Abstract] [Full Text] [Related]
14. Interleukin-13 in systemic sclerosis: relationship to nailfold capillaroscopy abnormalities. Riccieri V, Rinaldi T, Spadaro A, Scrivo R, Ceccarelli F, Franco MD, Taccari E, Valesini G. Clin Rheumatol; 2003 May; 22(2):102-6. PubMed ID: 12740673 [Abstract] [Full Text] [Related]
17. Nailfold capillaroscopy for prediction of novel future severe organ involvement in systemic sclerosis. Smith V, Riccieri V, Pizzorni C, Decuman S, Deschepper E, Bonroy C, Sulli A, Piette Y, De Keyser F, Cutolo M. J Rheumatol; 2013 Dec; 40(12):2023-8. PubMed ID: 24128778 [Abstract] [Full Text] [Related]
20. State of the art on nailfold capillaroscopy: a reliable diagnostic tool and putative biomarker in rheumatology? Cutolo M, Smith V. Rheumatology (Oxford); 2013 Nov; 52(11):1933-40. PubMed ID: 23620555 [Abstract] [Full Text] [Related] Page: [Next] [New Search]